{
    "clinical_study": {
        "@rank": "87496", 
        "arm_group": [
            {
                "arm_group_label": "Pre-emptive Ethanol Lock Therapy Group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard Ethanol Lock Therapy Group", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The study team will compare hospital length of stay (LOS) and attributable length of stay\n      (ALOS, the LOS attributable to CRI), in a randomized, un-blinded prospective trial utilizing\n      short-dwell ethanol-lock therapy (ELT) (4 hours to 24 hour dwell times per day, repeated for\n      up to 72 hours) placed within 24 hours of admission(Group 1, Preemptive ELT) versus ELT\n      placed at the time of first positive blood culture report (Group 2, Rescue ELT (Standard of\n      Care ).  ELT will be given in both groups, in combination with systemic antibiotics, for the\n      treatment of CRI (suspected or proven) of the blood in children with central catheters.\n      Participants will be enrolled from patients with hematologic/oncologic disorders and bone\n      marrow or hematopoetic stem cell transplants (BMT) admitted for care to Children's Hospital\n      of Michigan (CHM), a tertiary care pediatric hospital in Detroit, Michigan.  ALOS will be\n      defined as the number of hospital days between first symptoms of Catheter-related infection\n      (CRI) (or date of admission for those admitted with symptoms) and first negative blood\n      culture.\n\n      Study Hypothesis: The main hypothesis is that the short-dwell ethanol-lock therapy, defined\n      above, placed within 24 hours of symptoms/admission (Arm 1) versus ELT placement at the time\n      of first positive blood culture report (Arm 2), with concomitant systemic antibiotics, for\n      the treatment of CRI (suspected or proven) of the blood in children with central catheters\n      in the H/O/BMT population will have shorter hospital length of stay (LOS) and attributable\n      LOS (ALOS) and therefore lower hospital costs."
        }, 
        "brief_title": "Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Leukemia", 
            "Lymphoma", 
            "Stem Cell Transplant", 
            "Hematogenous Disorders", 
            "Solid Tumors"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study team will compare hospital length of stay (LOS) and attributable length of stay\n      (ALOS, the LOS attributable to CRI), in a randomized, un-blinded prospective trial utilizing\n      short-dwell ethanol-lock therapy (ELT) (4 hours to 24 hour dwell times per day, repeated for\n      up to 72 hours) placed within 24 hours of admission(Group 1, Preemptive ELT) versus ELT\n      placed at the time of first positive blood culture report (Group 2, Rescue ELT (Standard of\n      Care ).\n\n      ELT will be given in both groups, in combination with systemic antibiotics, for the\n      treatment of Catheter-related Infection (CRI) (suspected or proven) of the blood in children\n      with central catheters.   Participants will be enrolled from patients with\n      hematologic/oncologic disorders and bone marrow or hematopoetic stem cell transplants\n      admitted for care to Children's Hospital of Michigan (CHM), a tertiary care pediatric\n      hospital in Detroit, Michigan.  ALOS will be defined as the number of hospital days between\n      first symptoms of CRI (or date of admission for those admitted with symptoms) and first\n      negative blood culture.\n\n      Aim 1: Compare two different treatment regimens for CRI using ELT (the preemptive ELT vs.\n      standard of care) by way of a prospective, randomized, two-arm study.\n\n      Study Hypothesis: The main hypothesis is that the short-dwell ethanol-lock therapy, defined\n      above, placed within 24 hours of symptoms/admission (Arm 1) versus ELT placement at the time\n      of first positive blood culture report (Arm 2), with concomitant systemic antibiotics, for\n      the treatment of CRI (suspected or proven) of the blood in children with central catheters\n      in the H/O/BMT population will have shorter hospital length of stay (LOS) and attributable\n      LOS (ALOS) and therefore lower hospital costs.\n\n      Aim 2: Compare sterilization rate of the infected intravascular device after ethanol-lock\n      therapy (as defined by a negative blood culture obtained from the infected catheter 24 - 72\n      hours after ELT) and central catheter salvage rate after CRI using ELT in the two study\n      arms.  If the central catheter is salvaged for further clinical use, recurrence of infection\n      (re-infection) of the central catheter for 28 days from date of first ELT procedure will\n      also be assessed.\n\n      Aim 3: Assess tolerability and adverse effects of the ELT (safety).\n\n      Aim 4: Perform sub-group analysis on the BSI episodes meeting National Healthcare Safety\n      Network (NHSN) criteria for laboratory confirmed central line associated BSI (CLABSI) into\n      the three categories of Criteria 1, 2 or 3 within the pediatric"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All children up to 21 years of age, with central catheters (any type) that develop\n             symptoms and are admitted to CHM with an underlying H/O/BMT diagnosis for individual\n             episodes of suspected or proven CRI of the blood, including rule out sepsis, will be\n             screened for potential participation in this study.\n\n          -  Individual CRI episodes in the same patient will be defined as a distinct central\n             catheter associated blood stream infection if separated by greater than 28 days from\n             prior ELT procedure and caused by a different organism identified on culture than the\n             prior central catheter associated blood stream infection episode.\n\n          -  Participants meeting study enrollment criteria will be offered participation and must\n             have parental full informed consent, adolescent assent and young child verbal assent\n             prior to enrollment as applicable.\n\n        Exclusion Criteria:\n\n          -  Children with documented allergy to ethanol or alcohol will be excluded. Blood\n             cultures from patients that are reported positive for pathogen growth within 12 hours\n             from the time they are obtained will be excluded from the study.\n\n          -  Any patient at CHM with an infected central catheter and with another indwelling\n             foreign body that communicates directly with the bloodstream, of which infection or\n             colonization could not be excluded directly, will also be excluded from the study\n             (i.e. Left Ventricular Assist Device) as it will not be possible to assess\n             sterilization of the central catheter.\n\n          -  Any patient with endocarditis or presumed endovascular infection will also be\n             excluded.\n\n          -  Any patient deemed critically ill or unstable, upon admission or during the early\n             treatment course, in which case the treating clinician(s) feel that immediate line\n             removal is potentially life-saving will be excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02095951", 
            "org_study_id": "2024.11"
        }, 
        "intervention": {
            "arm_group_label": [
                "Pre-emptive Ethanol Lock Therapy Group", 
                "Standard Ethanol Lock Therapy Group"
            ], 
            "description": "Participants will be randomized to receive early (preemptive) ELT (after 12 hours from time blood culture drawn, but before blood culture positive, R/O sepsis) with systemic antimicrobials versus standard ELT (placed in catheter when blood culture is positive for growth of a germ) with systemic antimicrobials.", 
            "intervention_name": "Ethanol lock therapy (ELT)", 
            "intervention_type": "Drug", 
            "other_name": "70% Ethanol in water"
        }, 
        "intervention_browse": {
            "mesh_term": "Ethanol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Detroit", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48201"
                }, 
                "name": "Children's Hospital of Michigan"
            }, 
            "investigator": {
                "last_name": "Eric J McGrath, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter Associated Bloodstream Infection: Impact on Length of Stay and Catheter Salvage", 
        "overall_contact": {
            "email": "EMcgrath@dmc.org", 
            "last_name": "Eric J McGrath, MD", 
            "phone": "313-745-5862"
        }, 
        "overall_contact_backup": {
            "email": "rarora@med.wayne.edu", 
            "last_name": "Ranu Arora, BS, CCRP", 
            "phone": "313-996-0488"
        }, 
        "overall_official": {
            "affiliation": "Wayne State University", 
            "last_name": "Eric J McGrath, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "A primary endpoint of this study is length of stay (LOS) per catheter infection episode/admission", 
                "measure": "Length of stay (LOS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
            }, 
            {
                "description": "A primary outcome of this study of attributable length of stay (ALOS) per individual infection episode/admission", 
                "measure": "Attributable Length of Stay (ALOS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
            }, 
            {
                "description": "Hospital costs per episode length of stay will be analyzed per infection episode/admission.", 
                "measure": "Hospital Costs", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
            }
        ], 
        "reference": {
            "PMID": "21622689", 
            "citation": "McGrath EJ, Salloum R, Chen X, Jiang Y, Boldt-MacDonald K, Becker C, Chu R, Ang JY. Short-dwell ethanol lock therapy in children is associated with increased clearance of central line-associated bloodstream infections. Clin Pediatr (Phila). 2011 Oct;50(10):943-51. doi: 10.1177/0009922811409568. Epub 2011 May 27."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02095951"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Children's Hospital of Michigan", 
            "investigator_full_name": "Eric McGrath", 
            "investigator_title": "Assistant Professor of Pediatrics - Clinical", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Secondary endpoints include catheter sterilization rates per infection episode/admission", 
                "measure": "Catheter sterilization rates", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
            }, 
            {
                "description": "Catheters salvaged during the study will be analyzed per infection episode/admission", 
                "measure": "Catheter salvage rates", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
            }, 
            {
                "description": "Adverse events that are thought to be related to the actual study intervention, namely timing of ethanol lock placement, will be reviewed and reported for each individual infection episode/admission.", 
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks but up to 1 month post the last ethanol dose administration"
            }, 
            {
                "description": "Re-infection of a salvaged catheter with same or new organism(s) will be recorded and analyzed.", 
                "measure": "Re-infection rates", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 2 weeks but for up to 1 month total"
            }
        ], 
        "source": "Children's Hospital of Michigan", 
        "sponsors": {
            "collaborator": {
                "agency": "Blue Cross Blue Shield of Michigan Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Children's Hospital of Michigan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}